4.5 Article

Hepatitis C virus NS3/4A protease blocks IL-28 production

Journal

EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 42, Issue 9, Pages 2374-2382

Publisher

WILEY
DOI: 10.1002/eji.201242388

Keywords

Hepatitis C virus; IL-28; Interferon lambda (IFN-?); NS3; 4A protease

Categories

Funding

  1. National Key Programs on Infectious Disease [2012ZX10002007-003, 2008ZX10002-014]
  2. MOST 973 Program [2009CB522501, 2009CB522504]
  3. Chinese Academy of Science [KSCX1-YW-10]
  4. Shanghai Pasteur Health Research Foundation [SPHRF2009001]
  5. SA-SIBS Scholarship
  6. Pasteur ACIP Program

Ask authors/readers for more resources

Type I interferons (IFNs), including IFN-a, -beta, and -?, play a critical role in innate immune responses against viral infection. IFN-?, including IL-29, IL-28A, and IL-28B, recently identified as a new subfamily of IFN named type III IFN, has also been demonstrated to suppress virus replication in vitro and in vivo. However, the molecular mechanisms that regulate the induction of type III IFNs during viral infection remain elusive. Here, we demonstrate that IL-28 (IFN-? 2/3) IFN production, similar to type I IFN, represents a primary and direct host response to HCV genomic RNA transfection. IL-28 (IFN-?2/3) induction by HCV genomic RNA was dependent upon the activation of NF-?B and IRF3. We identified a minimal IL-28 promoter region consisting of putative NF-?B and IRF3-binding sites. Furthermore, we showed that HCV infection can inhibit HCV genomic RNA-induced IL-28 expression, and that the viral NS3/4A protease activity was responsible for this inhibitory effect. Our results present important evidence for the control of type III IFN response by HCV, and shed more light on the molecular mechanisms underlying the persistence of HCV infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

A Nanoparticle-Based Hepatitis C Virus Vaccine With Enhanced Potency

Yu Yan, Xuesong Wang, Peilan Lou, Zhenzheng Hu, Panke Qu, Dapeng Li, Qingchao Li, Yongfen Xu, Junqi Niu, Yongning He, Jin Zhong, Huang Zhong

JOURNAL OF INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

The pre-existing cellular immunity to Japanese encephalitis virus heterotypically protects mice from Zika virus infection

Weihong Zhang, Yongfen Xu, Fanfan Zhao, Marion Tarbe, Shuru Zhou, Weihong Wang, Shengyuan Zhang, Wei Zhang, Qiuping Xu, Lina Shi, Feng Yuan, Xinwen Lin, Shuai Liu, Jing Sun, Jincun Zhao, Yaling Yang, Xiaozhen Liang, Jin Zhong, Gang Long, Chengfeng Qin, Qibin Leng, Hong Tang

SCIENCE BULLETIN (2020)

Article Immunology

Junctional and somatic hypermutation-induced CX4C motif is critical for the recognition of a highly conserved epitope on HCV E2 by a human broadly neutralizing antibody

Chunyan Yi, Jing Xia, Lan He, Zhiyang Ling, Xuesong Wang, Yu Yan, Jiangjun Wang, Xinhao Zhao, Weiguo Fan, Xiaoyu Sun, Ronghua Zhang, Sheng Ye, Rongguang Zhang, Yongfen Xu, Liyan Ma, Yaguang Zhang, Honglin Zhou, Zhong Huang, Junqi Niu, Gang Long, Junxia Lu, Jin Zhong, Bing Sun

Summary: The study aims to induce broadly neutralizing monoclonal antibodies that bind to the viral envelope glycoproteins of hepatitis C virus (HCV). The 8D6 antibody generated in this study shows broadly neutralizing activity by targeting a conserved epitope on the E2 protein. Reconstruction of the 8D6 inferred germline (iGL) demonstrated potential binding affinity and neutralization activity.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Chemistry, Medicinal

IL-1β Enhances the Antiviral Effect of IFN-α on HCV Replication by Negatively Modulating ERK2 Activation

Mingzhe Guo, Liqing Ye, Tao Yu, Lin Han, Qingchao Li, Peilan Lou, Tianyu Gan, Xia Jin, Hui Xiao, Guangxun Meng, Jin Zhong, Yongfen Xu

ACS INFECTIOUS DISEASES (2020)

Article Pharmacology & Pharmacy

Anti-flavivirus activity of polyoxometalate

Yue Qi, Lin Han, Yanfei Qi, Xia Jin, Bo Zhang, Junqi Niu, Jin Zhong, Yongfen Xu

ANTIVIRAL RESEARCH (2020)

Article Virology

A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution

Yimin Tong, Qingchao Li, Rui Li, Yongfen Xu, Yu Pan, Junqi Niu, Jin Zhong

JOURNAL OF VIROLOGY (2020)

Article Immunology

Tupaia MAVS Is a Dual Target during Hepatitis C Virus Infection for Innate Immune Evasion and Viral Replication via NF-κB

Ling Xu, Dandan Yu, Yu-Lin Yao, Tianle Gu, Xiao Zheng, Yong Wu, Rong-Hua Luo, Yong-Tang Zheng, Jin Zhong, Yong-Gang Yao

JOURNAL OF IMMUNOLOGY (2020)

Article Microbiology

A novel cell culture system modeling the SARS-CoV-2 life cycle

Xiaohui Ju, Yunkai Zhu, Yuyan Wang, Jingrui Li, Jiaxing Zhang, Mingli Gong, Wenlin Ren, Sai Li, Jin Zhong, Linqi Zhang, Qiangfeng Cliff Zhang, Rong Zhang, Qiang Ding

Summary: A BSL-2 cell culture system for production of replication-competent SARS-CoV-2 virus-like-particles was developed. This system allows for the complete viral life cycle to be achieved and enhances biosafety measures. High-throughput antiviral screening was conducted, leading to the discovery of new drugs against SARS-CoV-2 infection.

PLOS PATHOGENS (2021)

Article Immunology

UNC93B1 curbs cytosolic DNA signaling by promoting STING degradation

Zhenliang He, Sichao Ye, Yifan Xing, Yaming Jiu, Jin Zhong

Summary: UNC93B1 acts as a trafficking chaperone for endosomal Toll-like receptors, while also playing a distinct role in cytosolic DNA-triggered cGAS-STING signaling pathway. Deficiency of UNC93B1 enhances innate immune responses to cytosolic DNA stimulation and DNA virus infection. UNC93B1 negatively regulates STING-mediated signaling responses by controlling the protein level of STING and its interaction with STING.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Article Microbiology

Development of a New Reverse Genetics System for Ebola Virus

Tianyu Gan, Dihan Zhou, Yi Huang, Shuqi Xiao, Ziyue Ma, Xiaoyou Hu, Yimin Tong, Huimin Yan, Jin Zhong

Summary: By establishing a new EBOV reverse genetics system, the process of studying viral replication can be simplified, allowing for the continuous propagation and infection of subviral particles in cell populations, providing a new tool for EBOV research.

MSPHERE (2021)

Review Virology

Hepatitis C virus genotype 4: A poorly characterized endemic genotype

Steve Leumi, Mohamed El Kassas, Jin Zhong

Summary: Genotype 4 (GT4) accounts for 13% of global hepatitis C virus (HCV) infections, predominantly in the Middle East and Africa, with recent spread to Europe. Understanding of the molecular features and appropriate therapeutics for HCV-GT4 is limited, requiring more basic research to develop research tools and better therapeutics.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Biochemistry & Molecular Biology

Mouse circulating extracellular vesicles contain virus-derived siRNAs active in antiviral immunity

Yuqiang Zhang, Yunpeng Dai, Jiaxin Wang, Yan Xu, Zhe Li, Jinfeng Lu, Yongfen Xu, Jin Zhong, Shou-Wei Ding, Yang Li

Summary: The entry of virus-derived small-interfering RNAs (vsiRNAs) into the bloodstream through extracellular vesicles (EVs) is a mechanism for systemic antiviral RNA interference (RNAi) in mice. Vaccination with a live-attenuated virus deficient in RNAi suppression induces the production of stable vsiRNAs that confer protective immunity against virus infection.

EMBO JOURNAL (2022)

Article Microbiology

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion

Wenlin Ren, Xiaohui Ju, Mingli Gong, Jun Lan, Yanying Yu, Quanxin Long, Devin J. Kenney, Aoife K. O'Connell, Yu Zhang, Jin Zhong, Guocai Zhong, Florian Douam, Xinquan Wang, Ailong Huang, Rong Zhang, Qiang Ding

Summary: The SARS-CoV-2 variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618, recently identified in India, have shown increased transmissibility and evasive immune properties. These variants exhibit enhanced binding affinity with ACE2 orthologs in mice, marmosets, and koalas, while still using human ACE2 with no or slightly increased efficiency. The P681R mutation in these variants facilitates spike cleavage and viral entry. Additionally, the mutations E484Q, T478K, Delta 145-146, or E484K reduce their sensitivity to neutralizing antibodies but they remain sensitive to entry inhibitors like ACE2-Ig decoy receptor. These findings highlight the rapid spread of these variants and suggest the potential use of ACE2-Ig as a broad-spectrum antiviral strategy.
Article Virology

Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance

Chaolun Liu, Mingzhe Guo, Lin Han, Jie Lu, Xiaogang Xiang, Qing Xie, Janin Nouhin, Veasna Duong, Yimin Tong, Jin Zhong

Summary: Despite the development of highly effective direct-acting antivirals (DAAs), hepatitis C virus (HCV) infection remains a challenge to human public health. This study shows that a novel GT-6a HCV replicon can easily develop resistance to sofosbuvir (SOF), calling for attention to potential drug resistance in HCV GT-6a patients during DAAs therapies.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Virology

Discovery of a fused bicyclic derivative of 4-hydroxypyrrolidine and imidazolidinone as a new anti-HCV agent

Yifan Xing, Ran Chen, Feng Li, Bin Xu, Lin Han, Chaolun Liu, Yimin Tong, Yaming Jiu, Jin Zhong, Guo-Chun Zhou

Summary: In this study, a novel anti-HCV agent called HXL-10 was identified through screening using the HCV infection cell culture system. HXL-10 demonstrated potent antiviral activity with low cytotoxicity and high specificity. Mechanistic studies showed that HXL-10 might inhibit HCV assembly by targeting host functions. This research provides a new approach for developing antiviral drugs targeting host functions involved in HCV infection.

VIROLOGY (2023)

No Data Available